title: Diabetes: Should we treat infection or inflammation to prevent T2DM?
authors.forename: Outi
authors.initials: O
authors.lastname: Vaarala
authors.forename: Hannele
authors.initials: H
authors.lastname: Yki-Järvinen
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000517:prevention & control*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000188:drug therapy*; D012307:Risk Factors
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents